Market Access News | pharmaphorum

News

Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.

News

One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.

News

AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer - TROP2-directed Datroway.

News

Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras?

News

On their way out the door, the Biden administration has dropped the list of the next 15 drugs to be negotiated by Medicare.

News

AstraZeneca's BTK inhibitor Calquence is the first drug in the class to be approved in the US for first-line treatment of mantle cell lymphoma.